Cryopreserved platelets: are we there yet?

Transfusion

Volumn 58, Issue 9, 2018, Pages 2092-2094

  Marks, Denese C ^a,b  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE; PHOSPHATIDYLSERINE; THROMBIN;

ADVERSE EVENT; BLEEDING; BLOOD CLOTTING DISORDER; CELL SURVIVAL; CRYOPRESERVATION; EDITORIAL; HEMOSTASIS; HUMAN; THROMBOCYTE; THROMBOCYTE FUNCTION; THROMBOCYTE TRANSFUSION; THROMBOSIS; THROMBOCYTOPENIA;

BLOOD PLATELETS; CRYOPRESERVATION; HUMANS; THROMBOCYTOPENIA;

EID: 85053186803     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14887     Document Type: Editorial

References (28)

1. Handin RI, Valeri CR. Improved viability of previously frozen platelets. Blood 1972;40:509-13.
2. Valeri CR, Ragno G, Khuri S. Freezing human platelets with 6 percent dimethyl sulfoxide with removal of the supernatant solution before freezing and storage at −80 degrees C without postthaw processing. Transfusion 2005;45:1890-8.
3. Crowley JP, Rene A, Valeri CR. Changes in platelet shape and structure after freeze preservation. Blood 1974;44:599-603.
4. Spector JI, Skrabut EM, Valeri CR. Oxygen consumption, platelet aggregation and release reactions in platelets freeze-preserved with dimethylsulfoxide. Transfusion 1977;17:99-109.
5. Barnard MR, MacGregor H, Ragno G, et al. Fresh, liquid-preserved, and cryopreserved platelets: adhesive surface receptors and membrane procoagulant activity. Transfusion 1999;39:880-8.
6. Valeri CR. Hemostatic effectiveness of liquid-preserved and previously frozen human platelets. N Engl J Med 1974;290:353-8.
7. Vecchione JJ, Melaragno AJ, Hollander A, et al. Circulation and function of human platelets isolated from units of CPDA-1, CPDA-2, and CPDA-3 anticoagulated blood and frozen with DMSO. Transfusion 1982;22:206-9.
8. Zaroulis CG, Spector JI, Emerson CP, et al. Therapeutic transfusions of previously frozen washed human platelets. Transfusion 1979;19:371-8.
9. Schiffer CA, Aisner J, Wiernik PH. Frozen autologous platelet transfusion for patients with leukemia. N Engl J Med 1978;299:7-12.
10. Schiffer CA, Aisner J, Dutcher JP, et al. A clinical program of platelet cryopreservation. Prog Clin Biol Res 1982;88:165-80.
11. Schiffer CA, Aisner J, Dutcher JP. Platelet cryopreservation using dimethyl sulfoxide. Ann N Y Acad Sci 1983;411:161-9.
12. Lelkens CC, Koning JG, de Kort B, et al. Experiences with frozen blood products in the Netherlands military. Transfus Apher Sci 2006;34:289-98.
13. Noorman F, van Dongen TT, Plat MJ, et al. Transfusion: −80 degrees C frozen blood products are safe and effective in military casualty care. PLoS One 2016;11:e0168401.
14. Neuhaus SJ, Wishaw K, Lelkens C. Australian experience with frozen blood products on military operations. Med J Aust 2010;192:203-5.
15. Cohn CS, Dumont LJ, Lozano M, et al. Vox Sanguinis International Forum on platelet cryopreservation. Vox Sang 2017;112:e69-85.
16. Yilmaz S, Cetinkaya RA, Eker I, et al. Freezing of apheresis platelet concentrates in 6% dimethyl sulfoxide: the first preliminary study in Turkey. Turk J Haematol 2016;33:28-33.
17. Hess JR. Resuscitation of trauma-induced coagulopathy. Hematology Am Soc Hematol Educ Program 2013;2013:664-7.
18. Pidcoke HF, Aden JK, Mora AG, et al. Ten-year analysis of transfusion in Operation Iraqi Freedom and Operation Enduring Freedom: increased plasma and platelet use correlates with improved survival. J Trauma Acute Care Surg 2012;73:S445-52.
19. Peralta R, Vijay A, El-Menyar A, et al. Early high ratio platelet transfusion in trauma resuscitation and its outcomes. Int J Crit Illn Inj Sci 2016;6:188-93.
20. Delaney M, Stark PC, Suh M, et al. Massive transfusion in cardiac surgery: the impact of blood component ratios on clinical outcomes and survival. Anesth Analg 2017;124:1777-82.
21. Johnson L, Coorey CP, Marks DC. The hemostatic activity of cryopreserved platelets is mediated by phosphatidylserine-expressing platelets and platelet microparticles. Transfusion 2014;54:1917-26.
22. Cid J, Escolar G, Galan A, et al. In vitro evaluation of the hemostatic effectiveness of cryopreserved platelets. Transfusion 2016;56:580-6.
23. Tegegn TZ, De Paoli SH, Orecna M, et al. Characterization of procoagulant extracellular vesicles and platelet membrane disintegration in DMSO-cryopreserved platelets. J Extracell Vesicles 2016;5:30422.
24. Khuri SF, Healey N, MacGregor H, et al. Comparison of the effects of transfusions of cryopreserved and liquid-preserved platelets on hemostasis and blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1999;117:172-83 discussion 83-4.
25. Gerber B, Alberio L, Rochat S, et al. Safety and efficacy of cryopreserved autologous platelet concentrates in HLA-alloimmunized patients with hematologic malignancies. Transfusion 2016;56:2426-37.
26. Slichter SD, Cancelas J, Jones M, et al. Safety and efficacy of cryopreserved platelets in bleeding thrombocytopenic patients. Transfusion 2018;58:0000-0.
27. Bohonek M, Landova L, Kutac D. Frozen platelets in clinical use. Vox Sang 2016;111:60.
28. Reade MC. Frozen platelets: current practice, evidence, evidence gaps and clinical research programs underway. Vox Sang 2018;113:5-347.